Latest News

HOPA Members

HOPA President Combines People-First Approach with Oncology Pharmacy Expertise

HOPA officially welcomed Dr. Robert Mancini as its President at its annual conference in Portland, Oregon on April 11, 2025.

Neurofibromatosis
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Mirdametinib

Ramsey Shane, PharmD, MPH, PGY1 Pharmacy Resident, and Rebecca Pokorny, PharmD, BCPS, BCOP, Clinical Pharmacist Specialist Neuro-Oncology - both from Vanderbilt University Medical Center, Nashville, TN - write about mirdametinib (Gomekli).

Lung cancer x-ray image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Ensartinib

Savannah Young, PharmD, PGY1 Pharmacy Resident, from Sarasota Memorial Hospital, Sarasota, FL, and Kiera Roubal, PharmD, BCOP, Clinical Oncology Pharmacist Specialist, from Medical University of South Carolina, Charleston, SC, write about ensartinib.

Cancer cell image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Datopotamab deruxtecan-dlnk

Kasey Jackson, PharmD, BCOP, Clinical Oncology Pharmacy Specialist at Medical University of South Carolina, Charleston, SC, writes about datopotamab deruxtecan-dlnk (Datroway).

acute leukemia image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Revumenib

Andres Mariano, PharmD, PGY-2 Pediatric Oncology Pharmacy Resident, and Stephen Eng, PharmD, BCOP, Clinical Pharmacist - both from Memorial Sloan Kettering Cancer Center, New York, NY - write about revumenib (Revuforj).

Squamous cell carcinoma
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Cosibelimab-ipdl

Nathan Schieldt, PharmD, PGY2 Oncology Resident; William Morrissey, PharmD, PGY2 Oncology Resident; and Anna Clennon, PharmD, BCOP Clinical Pharmacist - all from Aurora St. Luke's Medical Center, Milwaukee, WI - write about cosibelimab-ipdl.

lung cancer x-ray
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Zenocutuzumab-zbco

Allen Barry, MBA, PharmD Candidate Class of 2025, and Alisha Vora, PharmD, BCOP, CPP, Clinical Pharmacist Practitioner, Gastrointestinal Medical Oncology - both from the University of North Carolina, Chapel Hill, NC - write about zenocutuzumab-zbco.

Advocacy

HOPA Signs Letter in Support of Cancer Research Funding and Infrastructure

Thirty-three organizations have signed a letter in support of cancer research funding amid Executive Orders that threaten the stability of research infastructure.

CanerBuddy app
Advocacy Collaborations

HOPA, Bone Marrow & Cancer Foundation, and Walgreens Specialty Unite to Provide Oncology Pharmacy Education

HOPA, the Bone Marrow & Cancer Foundation (BMCF), and Walgreens Specialty Pharmacy have partnered on digital outreach resources and tools to support patients who are navigating the complexities of cancer treatment.

HOPA logo
Membership

We Remain Committed to the Oncology Pharmacy Community and All Cancer Patients

The HOPA Board monitors recent Executive Orders and reaffirms the association's commitment to supporting our community of hematology/oncology pharmacists and all patients with cancer.

Pills photo
Tools and Resources

Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program

The HOPA OCC, with the participation of ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs).

Woman diagnosing breast cancer
HOPA News Late Breaking News

Late-Breaking HOPA News: Fam-trastuzumab deruxtecan-nxki for HER2 Ultralow Metastatic Breast Cancer

The ability of fam-trastuzumab deruxtecan-nxki to treat breast cancer patients with HER2 IHC 0 with positive membrane staining up to IHC 3+ has changed the treatment paradigm for metastatic disease.